Neogen Corporation Stock Price and Value Analysis

Should you buy Neogen Corporation stock? (NasdaqGS:NEOG). Let's see how it does in our automated value investing analysis system.

  • This company is solid.
  • This stock is on sale.
  • This company has stable growth.
  • This company is making money at a modest rate.
  • This company pays no dividend.

Inside the NEOG Numbers

NEOG Price
(Neogen Corporation stock price per share)
[?] NEOG Fair Price
(based on intrinsic value)
[?] NEOG Safety Price (based on a variable margin of safety) $12.36
[?] PE Ratio versus Sector 35% lower than other Healthcare stocks
[?] PE Ratio versus Industry 0% lower than other Diagnostics & Research stocks
[?] Cash Yield 2.75%
[?] Free Cash Flow Jitter 17%

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 12,843,890 shares shorted. With 107,738,519 shares available for purchase and an average trading volume over the past 10 trading days of 2,941,240, it would take at least 4.367 days for all of the short holders to cover their shorts.

Is Neogen Corporation Stock on Sale?

We believe that Neogen Corporation may be worth examining further. It's making money, which is a very positive sign. Is it on sale?

Neogen Corporation looks like a price in the fair value range. Based on our analysis—if the company keeps making money the way it has been—you could be looking at a good stock. See Before You Buy for your next steps.

Should You Buy NEOG Stock?

Does Neogen Corporation have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.